Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

Human Gene Therapy

Volumn 8, Issue 9, 1997, Pages 1065-1072

  Yu, John S ^a,c   Burwick, Jennifer A ^a,c   Dranoff, Glenn ^b,c   Breakefield, Xandra O ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER IMMUNIZATION; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; GLIOMA; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MELANOMA B16; METASTASIS; MOUSE; NEUTROPHIL; NONHUMAN; RETROVIRUS; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR CELL; VIRUS RECOMBINANT;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0030854533     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.9-1065     Document Type: Article

References (31)

1. AUSMAN, J.I., SHAPIRO, W.R., and RALL, D.P. (1970) Studies on the chemotherapy of experimental brain tumors: Development of an experimental model. Cancer Res. 30, 2394-2400.
2. BALDWIN, G.C., GASSON, J.C., QUAN, S.G., FLEISCHMANN, J., WEISBART, R., OETTE, D., MITSUYASU, R.T., and GOLDE, D.W. (1988). Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc. Natl. Acad. Sci. USA 85, 2763-2766.
3. BARBA, D., HARDIN, J., RAY, J., and GAGE, F.H. (1993). Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg. 79, 729-735.
4. BRASSEUR, F., RIMOLDI, D., LIENARD, D., LETHE, B., CARREL, S., ARIENTI, F., SUTER, L., VANWIJCK, R., BOURLOND, A., HUMBLET, Y., et al. (1995). Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer 63, 375-380.
5. BRAUN, D.P., PENN, R.D., FLANNERY, A.M., HARRIS, J.E., MAHALEY, M.S., and SALCMAN, M. (1982). Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas. Neurosurgery 10, 203-209.
6. BULLARD, D.E., GILLESPIE, G.Y., MAHALEY, M.S., and BIGNER, D.D. (1986). Immunobiology of human gliomas. Semin. Oncol. 13, 94-109.
7. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
8. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
9. EZZEDDINE, Z.D., MARTUZA, R.L., PLATIKA, D., SHORT, M.P., MALICK, A., CHOI, B., and BREAKEFIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol. 3, 608-614.
10. FIDLER, I.J. (1975). Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35, 218-224.
11. FREEMAN, S.M., ABBOUD C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression with a fraction of the tumor mass is generally modified. Cancer Res. 53, 5274-5283.
12. GASSON, J.C., BALDWIN, G.C., SAKAMOTO, K.M., and DIPERSIO, J.F. (1990). The biology of human granulocyte-macrophage colony-stimulating factor (GM-CSF). Prog. Clin. Biol. Res. 352, 375-384.
13. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE PLAEN, E., LETHE, B., BRASSEUR, F., and BOON, T. (1994). Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930.
14. GOMEZ-CAMBRONERO, J., and SHA'AFI, R.I. (1991). Granulocyte-macrophage colony-stimulating factor and the neutrophil: Mechanisms of action. Adv. Exp. Med. Biol. 314, 35-71.
15. HU, X., CHAKRABORTY, N.G., SPORN, J.R., KURTZMAN, S.H., ERGIN, M.T., and MUKHERJI, B. (1996). Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine. Cancer Res. 56, 2479-2483.
16. HUMPHREY, P.A., WONG, A.J., VOGELSTEIN, B., ZALUTSKY, M.R., FULLER, G.N., ARCHER, G.E., FRIEDMAN, H.S., KWATRA, M.M., BIGNER, S.H., and BIGNER, D.D. (1990). Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl. Acad. Sci. USA 87, 4207-4211.
17. KURPAD, S.N., WIKSTRAND, C.J., and BIGNER, D.D. (1994). Immunobiology of malignant astrocytomas. Semin. Oncol. 21, 149-161.
18. KUSHNER, B.H., and CHEUNG, N.K. (1989). GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 73, 1936-1941.
19. PORGADOR, A., BANNERJI, R., WATANABE, Y., FELDMAN, M., GILBOA, E., and EISENBACH, L. (1993). Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. J. Immunol. 150, 1458-1470.
20. RAM, Z., WALBRIDGE, S., HEISS, J.D., CULVER, K.W., BLAESE, R.M., and OLDFIELD, E.H. (1994). In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. J. Neurosurg. 80, 535-540.
21. RECHT, L., TORRES, C.O., SMITH, T.W., RASO, V., and GRIFFIN, T.W. (1990). Transform receptor in normal and neoplastic brain tissue: Implications for brain-tumor immunotherapy. J. Neurosurg. 72, 941-945.
22. SAITO, S., BANNERJI, R., GANSBACHER, B., ROSENTHAL, F.M., ROMANENKO, P., HESTON, W.D., FAIR, W.R., and GILBOA, E. (1994). Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res. 54, 3516-3520.
23. + cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc. Natl. Acad. Sci. USA 93, 10399-10404.
24. SHORT, M.P., CHOI, B.C., LEE, J.K., MALICK, A., BREAKEFIELD, X.O., and MARTUZA, R.L. (1990). Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J. Neurosci. Res. 27, 427-439.
25. TAKAMIYA, Y., SHORT, M.P., EZZEDDINE, Z.D., MOOLTEN, F.L., BREAKEFIELD, X.O., and MARTUZA, R.L. (1992). Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res. 33, 493-503.
26. TAPSCOTT, S.J., MILLER, A.D., OLSON, J.M., BERGER, M.S., GROUDINE, M., and SPENCE, A.M. (1994). Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc. Natl. Acad. Sci. USA 91, 8185-8189.
27. TJUVAJEV, J., GANSBACHER, B., DESAI, R., BEATTIE, B., KAPLITT, M., MATEI, C., KOUTCHER, J., GILBOA, E., and BLASBERG, R. (1995). RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 interferon gamma. Cancer Res. 55, 1902-1910.
28. VIEWEG, J., ROSENTHAL, F.M., BANNERJI, R., HESTON, W.D., FAIR, W.R., GANSBACHER, B., and GILBOA, E. (1994). Immunotherapy of prostate cancer in the Dunning rat model: Use of cytokine gene modified tumor vaccines. Cancer Res. 54, 1760-1765.
29. WAKIMOTO, H., ABE, J., TSUNODA, R., AOYAGA, M., HIRAKAWA, K., and HAMADA, H. (1996). Intensified antitumor immunity by a cancer vaccine that produces granulocyte macrophage colony-stimulating factor plus interleukin 4. Cancer Res. 56, 1828-1833.
30. WEI, M.X., TAMIYA, T., HURFORD, R.K.J., BOVIATSIS, E.J., TEPPER, R.I., and CHIOCCA, E.A. (1995). Enhancement of Interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum. Gene Ther. 6, 437-443.
31. YU, J.S., WEI, M.X., CHIOCCA, E.A., MARTUZA, R.L., and TEPPER, R.I. (1993). Treatment of glioma by engineered interleukin-4-secreting cells. Cancer Res. 53, 3125-3128.